These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 3076406)

  • 1. The real difficulties for malaria sporozoite vaccine development: nonresponsiveness and antigenic variation.
    Good MF; Kumar S; Miller LH
    Immunol Today; 1988 Nov; 9(11):351-5. PubMed ID: 3076406
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of asexual blood stage malaria vaccines.
    Kidson C
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):391-6. PubMed ID: 3064322
    [No Abstract]   [Full Text] [Related]  

  • 3. Sporozoite immunity and vaccine development.
    Hockmeyer WT; Ballou WR
    Prog Allergy; 1988; 41():1-14. PubMed ID: 3043419
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunology and molecular biology: targetting of a vaccine].
    Perrin LH; Mach B
    Ther Umsch; 1986 Feb; 43(2):148-54. PubMed ID: 3515610
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential non-responsiveness in humans of candidate Plasmodium falciparum vaccine antigens.
    Quakyi IA; Otoo LN; Pombo D; Sugars LY; Menon A; De Groot AS; Johnson A; Alling D; Miller LH; Good MF
    Am J Trop Med Hyg; 1989 Aug; 41(2):125-34. PubMed ID: 2672834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards a malaria vaccine: what is in sight?
    del Giudice G
    Allergol Immunopathol (Madr); 1991; 19(3):129-35. PubMed ID: 1799171
    [No Abstract]   [Full Text] [Related]  

  • 7. Construction and evaluation of a multistage combination vaccine against malaria.
    Zhang Q; Xue X; Qu L; Pan W
    Vaccine; 2007 Mar; 25(11):2112-9. PubMed ID: 17241708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic polymorphism in malaria: is it an important mechanism for immune evasion?
    Mendis KN; David PH; Carter R
    Immunol Today; 1991 Mar; 12(3):A34-7. PubMed ID: 2069676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Can malaria be eradicated by vaccination?].
    Stürchler D
    Schweiz Rundsch Med Prax; 1987 Sep; 76(36):975-80. PubMed ID: 3310179
    [No Abstract]   [Full Text] [Related]  

  • 10. Malaria vaccine development using synthetic peptides as a technical platform.
    Corradin G; Céspedes N; Verdini A; Kajava AV; Arévalo-Herrera M; Herrera S
    Adv Immunol; 2012; 114():107-49. PubMed ID: 22449780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunologic prevention of malaria].
    Wagner WH
    Med Monatsschr Pharm; 1990 Jul; 13(7):209-15. PubMed ID: 1695990
    [No Abstract]   [Full Text] [Related]  

  • 12. Cloned antigens from Plasmodium falciparum as malaria vaccine candidates.
    Pink JR; Caspers P; Etlinger H; Guttinger M; Matile H; Reber R; Schönfeld HJ; Sinigaglia F; Stüber D; Stürchler D
    Behring Inst Mitt; 1991 Feb; (88):142-6. PubMed ID: 2049031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-erythrocytic malaria vaccines to prevent Plasmodium falciparum malaria.
    Ballou WR; Kester KE; Heppner DG
    Chem Immunol; 2002; 80():253-61. PubMed ID: 12058643
    [No Abstract]   [Full Text] [Related]  

  • 14. [Malaria vaccine research].
    Sellioğlu B
    Mikrobiyol Bul; 1986 Jan; 20(1):37-41. PubMed ID: 3523172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malaria vaccines. Are they approaching reality?
    Perlmann P
    Nature; 1987 Jul 16-22; 328(6127):205-6. PubMed ID: 3299105
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccines for human malaria: epidemiological and immunological perspectives.
    Webster HK; Diggs CL; Ballou WR; Chulay JD
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):375-89. PubMed ID: 3064321
    [No Abstract]   [Full Text] [Related]  

  • 17. The malaria sporozoite vaccine: parasitology's brave new world.
    Spriggs DR
    J Infect Dis; 1985 Sep; 152(3):655-6. PubMed ID: 2411830
    [No Abstract]   [Full Text] [Related]  

  • 18. The development of molecular vaccines against malaria sporozoites.
    Ballou WR; Young JF; Cryz SJ; Sadoff JC
    Adv Exp Med Biol; 1989; 251():295-313. PubMed ID: 2692428
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential vaccine antigens of the asexual blood-stages of Plasmodium falciparum.
    Anders RF; Brown GV; Coppel RL; Stahl HD; Bianco AE; Favaloro JM; Crewther PE; Culvenor JG; Kemp DJ
    Dev Biol Stand; 1985; 62():81-9. PubMed ID: 2422079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte responsiveness to a candidate malaria sporozoite vaccine (R32tet32) of individuals with naturally acquired Plasmodium falciparum malaria.
    Webster HK; Ho M; Looareesuwan S; Pavanand K; Wattanagoon Y; Warrell DA; Hockmeyer WT
    Am J Trop Med Hyg; 1988 Jan; 38(1):37-41. PubMed ID: 3277463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.